Some previous reports had suggested apparently favorable outcomes in AML with germline DDX41 mutations (11, 51, 80); however, long-term follow up may be necessary to evaluate the genuine prognosis of AML with germline DDX41 mutations. The gene discussed is DDX41; the disease is acute myeloid leukemia.